BRODA Acne

Manufacturer
Bentley Laboratories, LLC
Effective date
2024-12-27
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 00:49:16

Label at a glance#

ProductBRODA Acne
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

Acne treatment and helps prevent new acne blemishes.

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day

Label contents#

Full prescribing information#

Drug Facts Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

acne treatment

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

 If swallowed, get medical help or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

Acne treatment and helps prevent new acne blemishes.

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, poloxamer 407, propylene glycol, PEG-400, laureth-4, menthol, bisabolol.

BRODA Acne Spot Treatment and Acne Treatment Pen Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Tough on acne

Gentle on your skin

Anti-acne IntelliGel™

BRODA Acne Spot Treatment

Broda Acne Treatment Pen

IntelliGel™ Technology
Suitable for sensitive skin

Maximum strength with 2% beta hydrox acid
Forms TrueSkin invisible patch
No peeling or flaking

Won't dry your skin

Alcohol-free Hydrogel

NET WT. 0.071 oz. (2g) - 0.71 oz. (20 g)

Distributed by:
Broda International, LLC
10 Barley Court
Plainsboro, NJ 08536
Manufactured and packaged in the USA
www.broda.com

Patent pending

BRODA™

Anti-acne IntelliGel™

Developed with a proprietary break-through IntellGel™ technology that delivers maximum strength acne medication to effectively penetrate pores to clear most acne blemishes and help prevent new acne pimples.

BrodaAcneSpot1 LabelBrodaAcneSpot1 Label

Broda AcneSpot2 LabelBroda AcneSpot2 Label

Broda AcneSpot3 LabelBroda AcneSpot3 Label

res

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1543172Broda Acne Spa 2 % Topical GelPSN5
346298salicylic acid 2 % Topical GelPSN5
1543172salicylic acid 0.02 MG/MG Topical Gel [Broda Acne Spa]SBD5
346298salicylic acid 0.02 MG/MG Topical GelSCD5
1543172Broda Acne Spa 0.02 MG/MG Topical GelSY5
1543172Broda Acne Spa 2 % Topical GelSY5
346298salicylic acid 2 % Topical GelSY5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54111-112-50BRODA Acne20 g in 1 TUBEGEL205
54111-112-51BRODA Acne2 g in 1 TUBEGEL25

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54111-112BRODA ACNE (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]5Current NDC, Legacy NDC, 2 package rows20241228_b7e1f105-8998-46a5-b1ae-85d21790b816.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZ1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
LAURETH-4INACTIVE INGREDIENT6HQ855798J1
LEVOMENOLINACTIVE INGREDIENT24WE03BX2T1
MENTHOLINACTIVE INGREDIENTL7T10EIP3A1
POLOXAMER 407INACTIVE INGREDIENTTUF2IVW3M21
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V31
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54111-11254111-112-50, 54111-112-51

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 15 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MENTHOLMENTHOLL7T10EIP3AGEL / TOPICAL0.1 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LAURETH-4LAURETH-46HQ855798JGEL / TOPICAL60 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LAURETH-4LAURETH-46HQ855798JGEL / TOPICAL60 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQGEL / TOPICAL6300 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / TOPICAL28 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LAURETH-4LAURETH-46HQ855798JGEL / TOPICAL60 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQGEL / TOPICAL6300 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MENTHOLMENTHOLL7T10EIP3AGEL / TOPICAL0.1 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / TOPICAL28 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYETHYLENE GLYCOL 400POLYETHYLENE GLYCOL 400B697894SGQGEL / TOPICAL6300 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLOXAMER 407POLOXAMER 407TUF2IVW3M2GEL / TOPICAL28 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MENTHOLMENTHOLL7T10EIP3AGEL / TOPICAL0.1 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRODA AcneSALICYLIC ACIDBentley Laboratories, LLCb7e1f105-8998-46a5-b1ae-85d21790b8162024-12-27WarningsExact identifier
ndc (package): 54111-112-50
ndc (package): 54111-112-51
ndc (product): 54111-112
ndc11 (package): 54111011251
ndc11 (package): 54111011250
spl id: d02e577d-3cb9-4906-ae3f-79f5ced8be19
spl set id: b7e1f105-8998-46a5-b1ae-85d21790b816

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.